Ost-müük Exicure, Inc. - XCUR CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.07 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 0.94 |
Avatud* | 0.92 |
Aastane muutus* | 384.21% |
Päeva ulatus* | 0.87 - 0.93 |
52 nädala ulatus | 0.63-10.16 |
Keskmine maht (10 päeva) | 11.68K |
Keskmine maht (3 kuud) | 3.19M |
Turukapitalisatsioon | 4.77M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 4.96M |
Tulu | 9.17M |
EPS | -9.35 |
Dividendid (% kasumist) | N/A |
Beeta | 1.00 |
Järgmine tuluaruande kuupäev | Mar 23, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Mar 22, 2023 | 0.93 | 0.01 | 1.09% | 0.92 | 0.94 | 0.87 |
Mar 21, 2023 | 0.94 | 0.01 | 1.08% | 0.93 | 0.96 | 0.93 |
Mar 20, 2023 | 0.94 | -0.01 | -1.05% | 0.95 | 0.97 | 0.94 |
Mar 17, 2023 | 0.98 | -0.05 | -4.85% | 1.03 | 1.03 | 0.96 |
Mar 16, 2023 | 0.95 | -0.07 | -6.86% | 1.02 | 1.02 | 0.95 |
Mar 15, 2023 | 1.02 | -0.01 | -0.97% | 1.03 | 1.03 | 1.00 |
Mar 14, 2023 | 1.04 | 0.03 | 2.97% | 1.01 | 1.06 | 0.99 |
Mar 13, 2023 | 1.04 | 0.01 | 0.97% | 1.03 | 1.04 | 0.99 |
Mar 10, 2023 | 1.03 | -0.08 | -7.21% | 1.11 | 1.11 | 0.99 |
Mar 9, 2023 | 1.12 | -0.04 | -3.45% | 1.16 | 1.16 | 1.10 |
Mar 8, 2023 | 1.09 | -0.04 | -3.54% | 1.13 | 1.13 | 1.08 |
Mar 7, 2023 | 1.12 | -0.01 | -0.88% | 1.13 | 1.15 | 1.12 |
Mar 6, 2023 | 1.14 | 0.00 | 0.00% | 1.14 | 1.15 | 1.12 |
Mar 3, 2023 | 1.13 | 0.06 | 5.61% | 1.07 | 1.14 | 1.07 |
Mar 2, 2023 | 1.09 | 0.00 | 0.00% | 1.09 | 1.13 | 1.07 |
Mar 1, 2023 | 1.11 | 0.02 | 1.83% | 1.09 | 1.11 | 1.07 |
Feb 28, 2023 | 1.13 | -0.04 | -3.42% | 1.17 | 1.20 | 1.08 |
Feb 27, 2023 | 1.20 | 0.00 | 0.00% | 1.20 | 1.22 | 1.18 |
Feb 24, 2023 | 1.12 | -0.04 | -3.45% | 1.16 | 1.16 | 1.10 |
Feb 23, 2023 | 1.14 | -0.02 | -1.72% | 1.16 | 1.21 | 1.14 |
Exicure, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kogutulu | -0.483 | 16.613 | 1.296 | 0.118 | 9.719 |
Tulu | -0.483 | 16.613 | 1.296 | 0.118 | 9.719 |
Kogu tegevuskulu | 62.066 | 42.049 | 27.913 | 21.937 | 21.154 |
Müük/Üldine/admin kulud, kokku | 13.087 | 9.955 | 8.573 | 7.818 | 7.046 |
Uuringud ja arendus | 48.979 | 32.094 | 19.34 | 14.119 | 14.108 |
Tulud majandustegevusest | -62.549 | -25.436 | -26.617 | -21.819 | -11.435 |
Intressitulud (kulu), muud tulud, neto | -1.542 | 0.446 | -0.065 | -0.672 | -0.795 |
Muud, neto | -0.011 | 0.322 | 0.379 | 0.078 | 0.191 |
Netotulu enne makse | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Netotulu pärast makse | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Netotulu enne erikulusid | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Netotulu | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Arvestatav tulu, v a erikulud | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Arvestatav tulu, koos erikuludega | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Jaotamisele kuuluv netotulu | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Keskmine jaotamisele kuuluv aktsia kohta | 2.95362 | 2.9065 | 1.9222 | 1.37284 | 1.3099 |
Jaotatav EPS, v a erakorralised kulud | -21.7029 | -8.4872 | -13.6838 | -16.3261 | -9.1908 |
Jaotamisele kuuluv normaal-EPS | -21.7029 | -8.4872 | -13.6838 | -16.3261 | -9.1908 |
Erakorralised kulud kokku | 0 | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kogutulu | 2.565 | 2.118 | -3.677 | 0.079 | 0.997 |
Tulu | 2.565 | 2.118 | -3.677 | 0.079 | 0.997 |
Kogu tegevuskulu | 10.302 | 15.567 | 19.404 | 13.941 | 13.154 |
Müük/Üldine/admin kulud, kokku | 3.162 | 4.15 | 2.947 | 3.098 | 2.892 |
Uuringud ja arendus | 7.14 | 11.417 | 16.457 | 10.843 | 10.262 |
Tulud majandustegevusest | -7.737 | -13.449 | -23.081 | -13.862 | -12.157 |
Intressitulud (kulu), muud tulud, neto | -0.591 | -0.372 | -0.445 | -0.405 | -0.32 |
Muud, neto | -0.02 | -0.004 | -0.005 | -0.002 | 0 |
Netotulu enne makse | -8.348 | -13.825 | -23.531 | -14.269 | -12.477 |
Netotulu pärast makse | -8.348 | -13.825 | -23.531 | -14.269 | -12.477 |
Netotulu enne erikulusid | -8.348 | -13.825 | -23.531 | -14.269 | -12.477 |
Netotulu | -8.348 | -13.825 | -23.531 | -14.269 | -12.477 |
Arvestatav tulu, v a erikulud | -8.348 | -13.825 | -23.531 | -14.269 | -12.477 |
Arvestatav tulu, koos erikuludega | -8.348 | -13.825 | -23.531 | -14.269 | -12.477 |
Jaotamisele kuuluv netotulu | -8.348 | -13.825 | -23.531 | -14.269 | -12.477 |
Keskmine jaotamisele kuuluv aktsia kohta | 4.03093 | 3.01522 | 2.93654 | 2.93449 | 2.92812 |
Jaotatav EPS, v a erakorralised kulud | -2.07099 | -4.58507 | -8.01317 | -4.86252 | -4.2611 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -2.07099 | -4.58507 | -8.01317 | -4.86252 | -4.2611 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Käibevarad kokku | 43.666 | 86.322 | 112.776 | 27.663 | 27.638 |
Raha ja lühiajalised investeeringud | 39.141 | 82.08 | 110.786 | 26.268 | 25.764 |
Raha ja ekvivalendid | 34.644 | 33.262 | 48.46 | 26.268 | 25.764 |
Laekumata arved, neto | 0 | 0.011 | 0.271 | 0.013 | 0.03 |
Accounts Receivable - Trade, Net | 0 | 0.011 | 0.035 | 0.003 | 0.013 |
Prepaid Expenses | 3.247 | 4.231 | 1.014 | 1.382 | 1.844 |
Total Assets | 64.868 | 100.444 | 115.263 | 28.756 | 28.987 |
Property/Plant/Equipment, Total - Net | 11.877 | 12.729 | 2.455 | 1.061 | 1.317 |
Property/Plant/Equipment, Total - Gross | 14.544 | 14.469 | 3.772 | 2.25 | 2.166 |
Accumulated Depreciation, Total | -2.667 | -1.74 | -1.317 | -1.189 | -0.849 |
Other Long Term Assets, Total | 9.325 | 1.393 | 0.032 | 0.032 | 0.032 |
Total Current Liabilities | 34.067 | 13.734 | 31.087 | 2.043 | 3.356 |
Accounts Payable | 3.413 | 1.866 | 1.814 | 0.5 | 1.049 |
Accrued Expenses | 6.464 | 3.525 | 2.435 | 1.543 | 1.273 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 6.873 | 0 | 4.965 | 0 | |
Other Current Liabilities, Total | 17.317 | 8.343 | 21.873 | 0 | 1.034 |
Total Liabilities | 53.636 | 38.938 | 34.516 | 7.804 | 9.012 |
Total Long Term Debt | 0 | 16.589 | 0 | 4.925 | 4.855 |
Long Term Debt | 0 | 16.589 | 0 | 4.925 | 4.855 |
Other Liabilities, Total | 19.569 | 8.615 | 3.429 | 0.836 | 0.801 |
Total Equity | 11.232 | 61.506 | 80.747 | 20.952 | 19.975 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
Common Stock | 0.011 | 0.009 | 0.009 | 0.004 | 0.004 |
Additional Paid-In Capital | 181.29 | 167.379 | 162.062 | 75.942 | 53.586 |
Retained Earnings (Accumulated Deficit) | -170.067 | -105.965 | -81.297 | -54.994 | -33.615 |
Total Liabilities & Shareholders’ Equity | 64.868 | 100.444 | 115.263 | 28.756 | 28.987 |
Total Common Shares Outstanding | 3.62574 | 2.92142 | 2.86869 | 1.47845 | 1.3099 |
Lühiajalised investeeringud | 4.497 | 48.818 | 62.326 | ||
Other Current Assets, Total | 1.278 | 0.705 | |||
Other Equity, Total | -0.002 | 0.083 | -0.027 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 29.182 | 43.666 | 64.147 | 60.647 | 73.987 |
Raha ja lühiajalised investeeringud | 26.384 | 39.141 | 60.838 | 56.059 | 67.436 |
Raha ja ekvivalendid | 23.89 | 34.644 | 51.885 | 42.587 | 34.296 |
Lühiajalised investeeringud | 2.494 | 4.497 | 8.953 | 13.472 | 33.14 |
Laekumata arved, neto | 0 | 0.027 | 0.044 | 0.224 | |
Accounts Receivable - Trade, Net | 0 | 0 | 0 | 0 | |
Prepaid Expenses | 1.669 | 3.247 | 2.173 | 3.642 | 5.02 |
Other Current Assets, Total | 1.129 | 1.278 | 1.109 | 0.902 | 1.307 |
Total Assets | 41.896 | 64.868 | 77.9 | 74.467 | 87.948 |
Property/Plant/Equipment, Total - Net | 11.393 | 11.877 | 12.288 | 12.383 | 12.535 |
Property/Plant/Equipment, Total - Gross | 14.359 | 14.544 | 14.661 | 14.473 | 14.346 |
Accumulated Depreciation, Total | -2.966 | -2.667 | -2.373 | -2.09 | -1.811 |
Other Long Term Assets, Total | 1.321 | 9.325 | 1.465 | 1.437 | 1.426 |
Total Current Liabilities | 21.361 | 34.067 | 21.98 | 12.745 | 12.763 |
Accounts Payable | 1.918 | 3.413 | 2.485 | 2.25 | 2.976 |
Accrued Expenses | 3.227 | 6.464 | 5.48 | 3.228 | 2.441 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 16.216 | 17.317 | 14.015 | 7.267 | 7.346 |
Total Liabilities | 38.66 | 53.636 | 63.917 | 37.827 | 37.907 |
Total Long Term Debt | 0 | 0 | 16.801 | 16.73 | 16.659 |
Long Term Debt | 0 | 16.801 | 16.73 | 16.659 | |
Other Liabilities, Total | 17.299 | 19.569 | 25.136 | 8.352 | 8.485 |
Total Equity | 3.236 | 11.232 | 13.983 | 36.64 | 50.041 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.012 | 0.011 | 0.009 | 0.009 | 0.009 |
Additional Paid-In Capital | 181.644 | 181.29 | 170.217 | 169.337 | 168.442 |
Retained Earnings (Accumulated Deficit) | -178.415 | -170.067 | -156.242 | -132.711 | -118.442 |
Other Equity, Total | -0.005 | -0.002 | -0.001 | 0.005 | 0.032 |
Total Liabilities & Shareholders’ Equity | 41.896 | 64.868 | 77.9 | 74.467 | 87.948 |
Total Common Shares Outstanding | 4.0931 | 3.62574 | 2.93666 | 2.93626 | 2.93283 |
Current Port. of LT Debt/Capital Leases | 0 | 6.873 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Raha majandustegevusest | -34.819 | -39.27 | 1.317 | -19.487 | -19.789 |
Raha majandustegevusest | 1.123 | 0.766 | 0.392 | 0.358 | 0.232 |
Mittelikviidsed varad | 4.048 | 2.896 | 1.981 | 2.179 | 1.437 |
Muutused tööjõus | 24.112 | -18.264 | 25.247 | 0.389 | -9.419 |
Tulu investeeringutelt | 43.085 | 10.142 | -63.432 | -0.094 | -0.926 |
Kapitalikulutused | -0.968 | -3.171 | -1.082 | -0.094 | -0.926 |
Rahavood investeeringutelt | 1.116 | 15.13 | 84.307 | 20.085 | 26.856 |
Rahavoogudesse investeerimine | -1.125 | -0.711 | -6.518 | -1.957 | -3.699 |
Aktsiate emiteerimine (tagasiost), neto | 12.241 | 3.34 | 90.825 | 22.042 | 31.556 |
Laenu väljastamine (kustutamine), neto | -10 | 12.501 | 0 | -1.001 | |
Rahaline kogumuutus | 9.382 | -13.998 | 22.192 | 0.504 | 6.141 |
Muud rahavood investeeringutelt, kokku | 44.053 | 13.313 | -62.35 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -8.348 | -64.102 | -50.277 | -26.746 | -12.477 |
Cash From Operating Activities | -12.756 | -34.819 | -21.022 | -25.885 | -14.809 |
Cash From Operating Activities | 0.302 | 1.123 | 0.829 | 0.546 | 0.263 |
Non-Cash Items | 1.006 | 4.048 | 3.04 | 1.578 | 0.693 |
Changes in Working Capital | -5.716 | 24.112 | 25.386 | -1.263 | -3.288 |
Cash From Investing Activities | 1.995 | 43.085 | 38.977 | 34.533 | 15.297 |
Capital Expenditures | -0.006 | -0.968 | -0.623 | -0.564 | -0.225 |
Other Investing Cash Flow Items, Total | 2.001 | 44.053 | 39.6 | 35.097 | 15.522 |
Cash From Financing Activities | -7.993 | 1.116 | 0.668 | 0.677 | 0.546 |
Financing Cash Flow Items | -0.507 | -1.125 | -0.009 | 0 | 0 |
Issuance (Retirement) of Stock, Net | 0.014 | 12.241 | 0.677 | 0.677 | 0.546 |
Issuance (Retirement) of Debt, Net | -7.5 | -10 | 0 | 0 | 0 |
Net Change in Cash | -18.754 | 9.382 | 18.623 | 9.325 | 1.034 |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Exicure, Inc. Company profile
Ettevõttest Exicure, Inc.
Exicure, Inc. on kliinilise faasi biotehnoloogia ettevõte. Ettevõte tegeleb neuroloogia, immunonkoloogia, põletikuliste haiguste ja muude geneetiliste haiguste ravimeetodite väljatöötamisega, mis põhinevad tema sfäärilise nukleiinhappe (SNA) tehnoloogial. Ettevõte arendab XCUR-FXNi, mis on sfäärilisel nukleiinhappel (SNA) põhinev ravikandidaat Friedreichi ataksia (FA) raviks. XCUR-FXN sisaldab SNA tehnoloogia abil rohkem kui üht aktiivset oligonukleotiidi ühes SNA molekulis. Ettevõtte ravikandidaat kavrotolimood (AST-008) on Toll-like receptor 9 (TLR9) agonist, mis on mõeldud immunonkoloogilisteks rakendusteks, kasutades SNA tehnoloogiat. AST-008 on I faasi b/II kliinilises uuringus kaugelearenenud soliidtuumoriga patsientidel. TLR9 agonistid seonduvad TLR9-ga ja aktiveerivad seda.
Industry: | Bio Therapeutic Drugs |
2430 N. Halsted St.
CHICAGO
ILLINOIS 60614
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com